The length of telomeres, the protective caps at the end of chromosomes, in white blood cells may help predict the likelihood ...

In a novel theory, scientists at Arizona State University's Biodesign Institute propose a unifying explanation for the ...

Research led by Lancaster University has revealed clear evidence that changes in the orchestration of brain oxygenation ...

A research team has discovered that the two key pathological hallmarks of Alzheimer's -- tau protein and beta-amyloid -- affect brain circuits in distinct yet synergistic ways, particularly those ...

Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer's.

There is no cure. Between 1995 and 2021, around $42bn was poured into more than 1,000 clinical trials. Yet only a handful of ...

An international research team has identified key genetic factors that confer protective effects against Alzheimer's disease (AD) through a comprehensive genetic analysis of East Asian populations, ...

Prolonged rapid eye movement (REM) latency may be a potential marker for Alzheimer disease and Alzheimer disease and related dementias (AD/ADRD).

A paradigm-shifting study from the Centre for Addiction and Mental Health (CAMH) shows an experimental drug, GL-II-73, has the potential to restore memory and cognitive function in a mouse model of ...

In a groundbreaking theory, scientists at Arizona State University's Biodesign Institute propose a unifying explanation for the molecular chaos driving Alzheimer's disease.

Fact checked by Nick Blackmer Taking longer to fall into REM—the dream stage of sleep—is linked to a higher risk of Alzheimer ...

Sometimes a person with dementia can lose their inhibitions and may behave in ways that others find embarrassing. Sometimes a person with dementia can lose their inhibitions and may behave in ways ...